Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Innovation
Biotech
'Let that one go': Nkarta CEO urges US gov to drop China regs
Restrictions on Chinese science hurt the people that matter most—the patients—Nkarta CEO Paul Hastings told Fierce.
Gabrielle Masson
Oct 16, 2025 2:00pm
The Fierce 50 of 2024
Sep 9, 2024 5:00am
Lower drug prices won't hurt biotech innovation, 2 studies show
Jul 31, 2024 2:30pm
Regeneron exec draws boos as he touts innovation over cost
Dec 8, 2022 11:50pm
New era: Flagship CEO, Moderna chair's first annual letter
Jan 14, 2022 10:29am
Bayer to shutter San Francisco research hub after 10-year run
Jun 16, 2021 10:50am
